Abstract 862: Atypical protein kinase c inhibitors can repress epithelial to mesenchymal transition (type III) in malignant melanoma von Ratnayake, Wishrawana Sarathi, Acevedo-Duncan, Mildred

Volltext

Abstract 244: Inhibition of atypical PKC signaling enhances the sensitivity of glioblastoma cells towards Temozolomide therapy von Dey, Avijit, Patel, Rekha, Smalley, Tracess, Ratnayake, Wishrawana Sarathi, Islam, Anisul, Acevedo-Duncan, Mildred

Volltext

Abstract 2857: Vimentin is a novel PKC-ι target facilitating migration and invasion in melanoma von Ratnayake, Wishrawana Sarathi, Breedy, Sloan, Apostolatos, Christopher, Hill, Robert, Dennison, Clare, Acevedo-Duncan, Mildred

Volltext

Abstract 1044: PKC-ι and PKC-ζ are heavily responsible of up-regulating epithelial-mesenchymal transition (EMT) and activating Vimentin to facilitate cellular motility in prostate... von Ratnayake, Wishrawana Sarathi, Apostolatos, Christopher, Breedy, Sloan, Hill, Robert, Dennison, Clare, Acevedo-Duncan, Mildred

Volltext

Abstract 5204: ICAM-1 and IL-17E upregulate FOXO1 to suppress the expression of oncogenic PKC-ι in human melanoma von Ratnayake, Wishrawana Sarathi, Apostolatos, Christopher, Breedy, Sloan, Apostolatos, André, Acevedo-Duncan, Mildred

Volltext

Abstract 150: Prevalent PKC-ι/ζ signaling is crucial for apoptosis inhibition and invasiveness of glioblastoma through upregulation of Pdk1/Akt1/14-3-3 cascade and Smad2/3 von Ratnayake, Wishrawana Sarathi, Khalid, Khandker M., Breedy, Sloan, Lajmi, Luke, Smalley, Tracess, Apostolatos, Christopher A., Hill, Robert, Fackrell, James, Acevedo-Duncan, Mildred

Volltext

Method of Treating Melanoma Using an Inhibitor of an Atypical Protein Kinase C von ACEVEDO-DUNCAN, Mildred Enid, RATNAYAKE, Wishrawana Sarathi, OSTROV, David A

Volltext bestellen